课题基金 / 基金详情

REGULATION OF PROTEIN SYNTHESIS AND ERYTHROPOIESIS

REGULATION OF PROTEIN SYNTHESIS AND ERYTHROPOIESIS
蛋白质合成和红细胞生成的调节
批准号:
3225570
负责人:
IRVING M LONDON
金额:
$29.73万
依托单位国家:
美国
项目类别:
财政年份:
1979
资助国家:
美国
项目状态:
已结题
起止时间:
1979-01-01 至 1995-06-30

项目摘要

项目成果

IRVING M LONDON的其他基金

相似基金

相关文献

中文摘要
翻译
本研究的长期目标是阐明
英文摘要
The long-term objectives of this research are the elucidation of the regulation of hemoglobin synthesis in normal and abnormal hematologic conditions; emphasis is placed on the translational control of the synthesis of globin and other proteins in erythroid cells by heme and eIF- 2alpha kinases and on the relationship of this control to erythroid cell development and maturation. The specific aims include elucidation of: the structure-function relations of heme-regulated and double-stranded RNA activated eIF-2alpha kinase in the human hematologic disorders characterized by heme-deficiency. This research is relevant to eukaryotic cells generally and specifically it is significant for understanding the human anemias in which heme-deficiency occurs: iron-lack anemia, one of the most prevalent world-wide disorders, the anemia of lead poisoning, and the sideroblastic anemias. The experimental design and methods involve: the study of protein synthesis in situ in rabbit reticulocytes and their lysates and in vitro in components of these cells; the purification of the heme-regulated eIF-2alpha kinase; the study of the effects of heme and other metalloporphyrins on the eIF-2alpha kinase; and the cloning of the cDNAs of the eIF-2alpha kinases, the determination of their amino acid sequences and their ATP binding sites; the preparation of polyclonal and monoclonal antibodies to the eIF-2alpha kinases and the determination by immunofluorescence of the presence of the eIF-2alpha kinases in erythroid cells at different stages of development in normal man and in the heme- deficiency clinical disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GENE THERAPY FOR B THALASSEMIA AND SICKLE CELL ANEMIA
GENE THERAPY FOR B THALASSEMIA AND SICKLE CELL ANEMIA
GENE THERAPY FOR B THALASSEMIA AND SICKLE CELL ANEMIA
GENE THERAPY FOR B THALASSEMIA AND SICKLE CELL ANEMIA
海外基金